Literature DB >> 17656716

AAV vector integration sites in mouse hepatocellular carcinoma.

Anthony Donsante1, Daniel G Miller, Yi Li, Carole Vogler, Elizabeth M Brunt, David W Russell, Mark S Sands.   

Abstract

Adeno-associated viruses (AAV) are promising gene therapy vectors that have little or no acute toxicity. We show that normal mice and mice with mucopolysaccharidosis VII (MPS VII) develop hepatocellular carcinoma (HCC) after neonatal injection of an AAV vector expressing b-glucuronidase. AAV proviruses were isolated from four tumors and were all located within a 6-kilobase region of chromosome 12. This locus encodes several imprinted transcripts, small nucleolar RNAs (snoRNAs), and microRNAs. Transcripts from adjacent genes encoding snoRNAs and microRNAs were overexpressed in tumors. Our findings implicate this locus in the development of HCC and raise concerns over the clinical use of AAV vectors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656716     DOI: 10.1126/science.1142658

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  246 in total

Review 1.  Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challenges.

Authors:  Deepak Raj; Andrew M Davidoff; Amit C Nathwani
Journal:  Expert Rev Hematol       Date:  2011-10       Impact factor: 2.929

2.  Integration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver.

Authors:  Ali Nowrouzi; Magalie Penaud-Budloo; Christine Kaeppel; Uwe Appelt; Caroline Le Guiner; Philippe Moullier; Christof von Kalle; Richard O Snyder; Manfred Schmidt
Journal:  Mol Ther       Date:  2012-03-27       Impact factor: 11.454

Review 3.  Gene therapy for the treatment of chronic peripheral nervous system pain.

Authors:  William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

4.  AAV provides an alternative for gene therapy of the peripheral sensory nervous system.

Authors:  Andreas S Beutler
Journal:  Mol Ther       Date:  2010-04       Impact factor: 11.454

5.  Differential effects of DNA double-strand break repair pathways on single-strand and self-complementary adeno-associated virus vector genomes.

Authors:  Marcela P Cataldi; Douglas M McCarty
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

6.  Gene correction in human embryonic and induced pluripotent stem cells: promises and challenges ahead.

Authors:  Kazim H Narsinh; Joseph C Wu
Journal:  Mol Ther       Date:  2010-06       Impact factor: 11.454

7.  Treatment of phenylketonuria using minicircle-based naked-DNA gene transfer to murine liver.

Authors:  Hiu Man Viecelli; Richard P Harbottle; Suet Ping Wong; Andrea Schlegel; Marinee K Chuah; Thierry VandenDriessche; Cary O Harding; Beat Thöny
Journal:  Hepatology       Date:  2014-07-29       Impact factor: 17.425

8.  mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency.

Authors:  Jingsong Cao; Ding An; Mikel Galduroz; Jenny Zhuo; Shi Liang; Marianne Eybye; Andrea Frassetto; Eishi Kuroda; Aki Funahashi; Jordan Santana; Cosmin Mihai; Kerry E Benenato; E Sathyajith Kumarasinghe; Staci Sabnis; Timothy Salerno; Kimberly Coughlan; Edward J Miracco; Becca Levy; Gilles Besin; Joshua Schultz; Christine Lukacs; Lin Guey; Patrick Finn; Tatsuhiko Furukawa; Paloma H Giangrande; Takeyori Saheki; Paolo G V Martini
Journal:  Mol Ther       Date:  2019-04-23       Impact factor: 11.454

Review 9.  A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiforme.

Authors:  Thomas Wirth
Journal:  World J Exp Med       Date:  2011-12-20

10.  AAV-mediated gene editing via double-strand break repair.

Authors:  Matthew L Hirsch; R Jude Samulski
Journal:  Methods Mol Biol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.